NCT00769028 - AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

September 30, 2011

Conditions

Systemic Sclerosis

Interventions

DRUG

Hyperimmune caprine serum

Subcutaneous injection of serum, 1ml twice weekly for 6 months

DRUG

Albumin

Subcutaneous injection of albumin, 1ml twice weekly for 6 months

Trial Locations (1)

Centre for Rheumatology and Connective Tissue Diseases, Lower Ground Floor, Royal Free Hospital NHS Trust, Hampstead, London